Evidence map›Paper›PMID 38204220›Full record

ArticleCancer medicine2024

Heterogeneity-induced NGF-NGFR communication inefficiency promotes mitotic spindle disorganization in exhausted T cells through PREX1 suppression to impair the anti-tumor immunotherapy with PD-1 mAb in hepatocellular carcinoma.

Xin Wang, Tongwang Yang, Shangheng Shi, Chuanshen Xu, Feng Wang, Deshu Dai, Ge Guan, Yong Zhang, Shuxian Wang, Jianhong Wang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Therapeutic Potental of Quinolin-2Mini reviews in medicinal chemistry · 2025
    Review
  9. Role of LMO7 in cancer (Review).Oncology reports · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Xin WangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Tongwang YangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Shangheng ShiLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Chuanshen XuLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Feng WangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Deshu DaiLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Ge GuanLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yong ZhangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Shuxian WangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Jianhong WangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Bingliang ZhangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Peng LiuLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xiaoshuai BaiLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yan JinLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xinqiang LiLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Cunle ZhuLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Dexi ChenLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qingguo XuLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.ORCID 0000-0002-2001-5133
Yuan GuoLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qingdao University · CN

Funding

Beijing Municipal Natural Science Foundation and Beijing Municipal Education Commission KZ202010025037China Postdoctoral Science Foundation 2020M672003China Postdoctoral Science Foundation 2022T150341National Natural Science Foundation of China 81900575National Natural Science Foundation of China 82272973Youth Science Foundation of Affiliated Hospital of Qingdao University QYFY-2021-36
6 · The paper itself

Abstract

backgroundThe mechanism of decreased T cells infiltrating tumor tissues in hepatocellular carcinoma is poorly understood.

methodsCells were separated from the single-cell RNA-sequence dataset of hepatocellular carcinoma patients (GSE149614) for cell-cell communication. Flow cytometry, EDU staining, H3-Ser28 staining, confocal immunofluorescence staining, western blotting and naked microsubcutaneous tumors were performed for the mechanism of NGF-NGFR promoting proliferation.

resultsThe present study has revealed that during the process of T-cell infiltration from adjacent tissues to tumor tissues, an inefficiency in NGF-NGFR communication occurs in the tumor tissues. Importantly, NGF secreted by tumor cells interacts with NGFR present on the membranes of the infiltrated T cells, thereby promoting the proliferation through the activation of mitotic spindle signals. Mechanistically, the mediation of mitotic spindle signal activation promoting proliferation is executed by HDAC1-mediated inhibition of unclear trans-localization of PREX1. Furthermore, PD-1 mAb acts synergistically with the NGF-NGFR communication to suppress tumor progression in both mouse models and HCC patients. Additionally, NGF-NGFR communication was positively correlates with the PD-1/PDL-1 expression. However, expressions of NGF and NGFR are low in tumor tissues, which is responsible for the invasive clinicopathological features and the disappointing prognosis in HCC patients.

conclusionInefficiency in NGF-NGFR communication impairs PD-1 mAb immunotherapy and could thus be utilized as a novel therapeutic target in the treatment of HCC patients in clinical practice.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAnimalsGuanine Nucleotide Exchange FactorsHumansImmunotherapyMiceNerve Tissue ProteinsProgrammed Cell Death 1 ReceptorReceptors, Nerve Growth FactorT-LymphocytesGuanine Nucleotide Exchange FactorsNerve Tissue ProteinsNGFR protein, humanPREX1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, Nerve Growth Factorhepatocellular carcinomaimmunotherapynerve growth factornerve growth factor receptorpd-1

Identifiers

PMID38204220
PMCPMC10905245
OpenAlexW4390742439

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.